BioSpace News Archive

Drug Development

Athenex Announces Encouraging Results of the First Cohort of Phase I Clinical Trial of Oraxol and CYRAMZA (Ramucirumab) Comvric Cancer

A previously completed Phase II clinical trial of Oraxol in the second-line treatment of gastric cancer patients showed an encouraging overall median survival of 10.7 months.

January 22, 2018
·
5 min read
Biotech Beach

Cytori Therapeutics: Enrollment Completed in Randomized Clinical Trial of Habeo Cell Therapy for Scleroderma and Impaired Hand Function

In this investigator-initiated clinical trial supported by Cytori, a total of 40 patients were enrolled among 5 French centers.

January 22, 2018
·
7 min read
Drug Development

Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole

This phase 1/1b study will be conducted in healthy subjects and patients with mild to moderate stable asthma.

January 22, 2018
·
5 min read
Drug Development

Inovio Pharmaceuticals’ Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models

The flu vaccine also affords 100% protection against lethal challenge in the gold standard ferret model, demonstrating the functionality of such broad protective immune responses.

January 22, 2018
·
6 min read
BioMidwest

Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

The consensus recommendations point to the need for routine obtainment of family history information and hereditary cancer counselling for men with prostate cancer seen by either a urologist or oncologist.

January 22, 2018
·
6 min read
Business

Invetech Announces Senior Management Appointment

Invetech has announced the appointment of David Kneen as VP, Cell Therapy.

January 22, 2018
·
2 min read
Pharm Country

CluePoints Launches Risk-Based Monitoring Starter Pack to Drive Regulatory Compliance

The starter pack has been developed following CluePoints’ extensive market and industry research to better understand the challenges faced by clinical development organizations and CROs since the introduction of the ICH E6 (R2) addendum.

January 22, 2018
·
3 min read
Business

Blue Mesa Health to Partner With Merck KGaA, Darmstadt, Germany on Diabetes Prevention Program Pilot Programs Outside of the USA

Founded in 2015, Blue Mesa Health has designed and commercialized two chronic disease prevention programs based on the CDC’s landmark National Diabetes Prevention Program.

January 22, 2018
·
3 min read
Business

Poxel Announces Fourth Quarter 2017 Financial Update

During the fourth quarter, Poxel generated revenues of €5.2 million ($5.9 million).

January 22, 2018
·
6 min read
Policy

Orsiro Coronary Drug-Eluting Stent Receives Market Approval in Japan

BIOTRONIK announced today market approval for its Orsiro1 coronary drug-eluting stent by the Japanese Ministry of Health.

January 22, 2018
·
2 min read